Knee Replacement — Cost, Top Hospitals & Success Rates | MyMedicPlus

Knee replacement — or total knee arthroplasty (TKA) — is a surgical procedure in which the damaged surfaces of the knee joint are replaced with artificial implant components made from metal alloys and medical-grade plastic (polyethylene). The operation relieves pain, corrects deformity, and restores mobility in knees that have been destroyed by arthritis or injury.

It is one of the most common and most successful elective operations in the world. More than 800,000 procedures are performed annually in the United States and over 100,000 in the United Kingdom. Large registry studies show that more than 90% of patients experience significant pain relief, and modern implants last 15–25 years in the majority of patients. The UK National Joint Registry reports implant survival exceeding 90% at 20 years for primary TKA.

Despite its high success rate, knee replacement is a major operation that requires careful patient selection, meticulous surgical execution, and dedicated rehabilitation. It is not a first resort — surgery is appropriate only when a structured course of non-surgical treatment has failed to provide adequate relief. When indicated, however, it offers life-changing improvements in quality of life for the majority of recipients.

This guide answers the most common questions patients have about knee replacement: who needs it, what happens during surgery, what recovery looks like week by week, what activities you can return to, and what knee replacement costs around the world.

Knee replacement is indicated when arthritis or joint damage has reached a point where it causes persistent, disabling pain and significantly limits daily activities, and when non-surgical treatments have been tried for at least three to six months without adequate benefit.

Osteoarthritis (OA) accounts for more than 95% of knee replacements. In OA, the protective cartilage covering the joint surfaces gradually wears away, exposing bare bone and causing severe pain, stiffness, and deformity. The knee may bow inward (varus deformity) or outward (valgus deformity). By the time TKA is recommended, X-rays typically show bone-on-bone contact and significant joint space loss.

Rheumatoid arthritis (RA) is an autoimmune condition that causes inflammatory destruction of the knee joint lining (synovium), cartilage, and bone. RA can affect both knees simultaneously and often occurs at a younger age than OA. Many RA patients require bilateral (both knees) knee replacement.

Post-traumatic arthritis develops years after a severe knee injury — such as a fracture of the tibial plateau or femoral condyle, a severe ligament tear, or significant meniscal loss — that disrupts the joint architecture and accelerates cartilage wear.

You may be a candidate for knee replacement if:

• Knee pain is constant, disrupts sleep, and limits walking to short distances
• Stairs, rising from a chair, and getting in and out of a car have become difficult or impossible
• Anti-inflammatory medications, physiotherapy, and steroid injections have not provided lasting relief
• X-rays show severe arthritis with minimal or no remaining joint space

Symptoms alone do not determine timing — the decision is made jointly between patient and surgeon based on clinical examination, imaging findings, functional status, and the patient's own goals and preferences. Age above 60 and BMI under 35 are associated with the best outcomes, though TKA is successfully performed in patients outside these ranges with appropriate risk discussion.

Suitability for knee replacement involves a structured assessment by an orthopaedic surgeon, with input from your general practitioner (GP), physiotherapist, and often an anaesthetist. Key factors include:

What favours surgery: Severe radiographic arthritis (Kellgren-Lawrence grade 3–4 on weight-bearing X-rays); pain at rest and at night; inability to walk more than 200 metres without stopping; failure of physiotherapy, weight loss, and injections; strong motivation to engage with rehabilitation.

What may need optimisation first: Obesity (BMI >35–40) significantly increases complication risk; even 5–10% weight loss improves surgical outcomes. Uncontrolled type 2 diabetes (HbA1c >7.5%) raises infection risk and should be optimised before surgery. Active smoking doubles the risk of wound infection — smoking cessation programmes should be started at least 4–8 weeks pre-operatively. Severe cardiovascular or respiratory disease requires assessment and stabilisation by the relevant specialist.

What may prevent surgery: Active infection anywhere in the body (must be fully treated before joint replacement); absent or non-functional extensor mechanism (the quadriceps-patellar tendon system must be intact); severe peripheral arterial disease impairing wound healing; patient preference to avoid surgery after being fully informed.

Realistic expectations: Knee replacement is excellent for pain relief and improving walking ability. It is not designed for return to high-impact sport (running, football, skiing). Setting realistic expectations — what you can do after TKA, not just what you cannot — is essential. Studies show that patients with the best outcomes are those who engage fully with rehabilitation, maintain a healthy weight post-operatively, and understand the gradual nature of the 12-month recovery curve.

Not all knee replacements are the same. The type of surgery recommended depends on which parts of your knee are affected by arthritis, your anatomy, age, activity level, and surgical volume at your centre.

Total Knee Replacement (TKR/TKA): The most common type. All three compartments of the knee (medial, lateral, patellofemoral) are resurfaced. The end of the thigh bone (femur) is capped with a metal component; the top of the shin bone (tibia) receives a metal tray with a plastic (polyethylene) insert; the back of the kneecap may be resurfaced with a plastic button. TKA is appropriate for tricompartmental or severe bicompartmental arthritis.

Unicompartmental Knee Replacement (UKR/UKA): Only the most affected compartment — most commonly the inner (medial) side of the knee — is resurfaced, leaving the rest of the joint intact. UKA uses a smaller incision, preserves more bone and both cruciate ligaments, and allows a faster initial recovery. However, patient selection must be strict (isolated single-compartment OA, intact anterior cruciate ligament, correctable deformity) and the long-term revision rate is slightly higher than TKA. The Oxford medial UKA reports approximately 90% survival at 10 years.

Patellofemoral Replacement: Resurfaces only the patellofemoral joint (kneecap compartment) in isolated patellofemoral OA. A niche indication in carefully selected patients; risk of progression to tricompartmental OA requiring conversion to TKA.

Bilateral Knee Replacement: Both knees may be replaced at the same operation (simultaneous bilateral TKA) or as staged procedures (typically 6–12 weeks apart). Simultaneous bilateral TKA reduces total hospital time and anaesthetic exposure but is associated with higher blood loss and is typically reserved for younger, medically fit patients after careful counselling.

Robotic-assisted knee replacement: A CT scan taken before surgery creates a 3D model of your knee; the surgeon uses a robotic arm intra-operatively to make bone cuts with precise accuracy. This technology is increasingly available at specialist centres and produces more accurate implant positioning; long-term superiority in patient outcomes versus conventional TKA is still being established in randomised trials.

Knee replacement consistently delivers significant improvements in pain, function, and quality of life for the great majority of patients who have reached the point of surgical indication.

Pain relief: The most reliable outcome. Approximately 85–90% of patients experience significant or complete relief of their arthritis pain. Night pain — often the most distressing pre-operative symptom — typically resolves within weeks of surgery as post-operative swelling settles.

Recovery milestones (typical TKA):

• Day 0–1: Standing and taking first steps with physiotherapist support. Pain controlled with spinal anaesthesia and nerve blocks.
• Days 2–3: Walking with a frame; stair practice; meeting discharge criteria. Most patients go home on Day 2–3.
• Week 2: Walking indoors with crutches or a walking stick; wound review; suture/staple removal.
• Week 4–6: Progressing to one crutch or independent walking indoors; driving an automatic car (left knee) at 4–6 weeks; driving after right-sided TKA usually cleared at 6 weeks with ability to perform emergency braking — always confirm with your surgeon and insurer.
• Month 3: Walking normally for everyday activities; returning to office work; most people no longer need walking aids. Knee still swollen and warm — this is normal and continues improving for up to 12 months.
• Month 6: Returning to swimming, cycling, and golf. Significant further reduction in swelling. Most functional gains have been achieved.
• Month 12: Full functional recovery. Residual mild swelling and occasional discomfort are normal and continue improving slowly for up to two years.

Long-term function: Walking speed, stair-climbing, and rising from chairs improve progressively. Approximately 80–85% of TKA patients are satisfied or very satisfied at two years. Patients with the best outcomes are those under 70, BMI under 35, well-controlled comorbidities, high pre-operative function, and robust rehabilitation engagement.

Knee replacement is a major surgical procedure with recognised risks. Most complications are uncommon; serious complications are rare in experienced hands. Your surgeon will discuss these during the consent process.

Common short-term issues (not strictly complications): Swelling and bruising persist for 3–6 months and are a normal part of healing. Post-operative pain, stiffness, and fatigue are expected. Kneeling and full squatting are often permanently limited after TKA — the majority of patients find an acceptable range of motion for daily activities but should not expect to kneel comfortably on hard surfaces.

Blood clots (DVT/PE): Deep vein thrombosis and pulmonary embolism are the most common serious early complications. Prevented by blood-thinning medication (for 14–35 days), compression stockings, foot pumps, and early walking. Modern prophylaxis has reduced PE deaths to approximately 0.1–0.2% after TKA.

Infection: Periprosthetic joint infection (PJI) affects approximately 1–2% of primary TKA cases. Superficial wound infection (cellulitis) is treated with antibiotics; deep infection around the implant usually requires further surgery, potentially including implant removal and a two-stage revision procedure. Vigilance about dental procedures, skin infections, and other procedures that may introduce bacteria into the bloodstream is important for the lifetime of the implant.

Stiffness: Five to ten percent of patients achieve less than 90 degrees of knee flexion. Pre-operative stiffness is the strongest risk factor. Manipulation under anaesthesia (MUA) within the first 3 months may improve range of motion.

Revision surgery: The probability that a knee replacement will require revision surgery increases with time. Overall, approximately 2–3% of TKA patients require revision within 10 years. Causes include aseptic loosening (implant coming loose without infection), periprosthetic joint infection, instability, stiffness, polyethylene wear, and fracture around the implant. Revision surgery is significantly more complex than primary TKA and carries higher complication rates. Younger patients and heavier patients carry higher lifetime revision risk.

Other risks: Nerve injury (usually temporary); allergy to implant metals (nickel, cobalt — rare); fracture during surgery; blood vessel injury (<0.1%).

Knee replacement significantly expands physical capability for most patients but comes with lifelong activity recommendations designed to protect the implant and maximise its lifespan.

Activities encouraged after TKA:

• Swimming: Excellent low-impact cardiovascular exercise. Can begin once wound is fully healed (typically 6–8 weeks post-operatively). Breaststroke may be uncomfortable initially.
• Cycling: Both static and road cycling are excellent rehabilitation and maintenance exercises. Begin on a static bike at weeks 4–6 progressing to outdoor cycling by month 3.
• Golf: Can return at 3–4 months. Walking the course is preferred over cart-only golf for rehabilitation benefit.
• Walking and hiking: Encouraged from early recovery; unlimited distance once fully recovered. Uneven terrain by month 4–6.
• Doubles tennis: Generally acceptable; singles tennis is more demanding and discussed case-by-case.

Activities generally discouraged or to be discussed with surgeon:

• Running and jogging: High-impact repetitive loading accelerates polyethylene wear and is generally discouraged, though some surgeons permit occasional jogging in younger, lighter patients with cementless implants on a case-by-case basis.
• Skiing: Downhill skiing carries significant fall risk and torsional forces; not recommended by most orthopaedic societies. Cross-country skiing is lower risk.
• High-impact team sports: Football, basketball, squash — generally not recommended due to impact, pivoting, and collision risk.

Dental and medical procedures: For the lifetime of the implant, inform all treating clinicians (dentist, GP, emergency doctors) that you have a knee replacement. Current UK and US guidance does not recommend routine antibiotic prophylaxis before dental procedures in immunocompetent TKA patients, but peri-operative antibiotic cover remains standard for other surgical procedures. Always seek advice from your orthopaedic surgeon if unsure.

Follow-up imaging: X-rays are taken at annual reviews for the first two years, then 5-yearly. Any new knee pain or swelling — particularly if accompanied by systemic symptoms — should prompt urgent assessment to exclude infection or implant loosening.

The cost of knee replacement surgery varies enormously depending on the country, healthcare system, hospital type, and implant used. For patients considering travelling internationally for surgery, a realistic cost comparison is essential.

United Kingdom: Free on the NHS for eligible patients meeting clinical criteria (weight, BMI, and smoking status may influence NHS eligibility in some regions). NHS waiting lists can extend to 12–18 months in some areas. Private knee replacement in the UK costs GBP 10,000–18,000 including surgeon, anaesthetist, hospital stay, implant, and basic physiotherapy.

United States: Without insurance, total knee replacement costs USD 25,000–50,000 depending on state, hospital, and implant. With Medicare or employer insurance, patient out-of-pocket costs depend on plan structure. The average 90-day bundled episode cost (including post-acute care) is USD 18,000–30,000 under CMS bundled payment models.

Europe (private): Germany: EUR 14,000–22,000; France: EUR 10,000–16,000; Hungary and Czech Republic: EUR 7,000–12,000 (popular medical tourism destinations for EU citizens).

Asia (medical tourism):

• India: USD 4,000–8,000 (bilateral USD 7,000–12,000). JCI-accredited hospitals in Delhi, Mumbai, Chennai, and Bangalore offer high-quality TKA with internationally trained surgeons.
• Thailand: USD 8,000–14,000. Bangkok hospitals (Bumrungrad, Bangkok Hospital) are JCI-accredited and popular with international patients.
• Malaysia: USD 7,000–12,000. KL private hospitals offer competitive pricing with high standards.
• Singapore: USD 18,000–28,000. Premium pricing reflecting world-class facilities.

Latin America: Mexico: USD 7,000–15,000 (popular for US patients); Colombia: USD 6,000–10,000; Costa Rica: USD 8,000–14,000.

What the price should include: Surgeon fee; anaesthetist fee; hospital stay (2–4 nights); implant cost; operating theatre; physiotherapy for inpatient stay. Ensure travel insurance covers medical repatriation if complications occur during or after overseas surgery.

Knee replacement is a last resort after non-surgical options have been adequately tried. The following alternatives may delay or, in some cases, avoid the need for surgery:

Exercise and physiotherapy: The strongest evidence-based intervention for knee OA at any stage. Neuromuscular exercise programmes (GLAD, NEMEX) strengthen muscles around the knee, improve stability, and reduce pain — with benefits lasting 12–24 months. Aquatic (hydrotherapy) exercise is particularly valuable for patients with severe pain who struggle with land-based exercise. Your physiotherapist will design a programme tailored to your function and goals.

Weight management: Each kilogram of body weight reduction reduces the compressive force across the knee by approximately 4 kg. A loss of 10% body weight in overweight patients produces clinically significant pain reduction equivalent to many medical treatments. Weight loss also significantly reduces surgical risk when TKA eventually becomes necessary.

Medications: Topical anti-inflammatory gels (diclofenac) are first-line for older patients with mild-moderate OA. Oral NSAIDs (ibuprofen, naproxen, celecoxib) control pain and inflammation short-term but carry gastrointestinal and cardiovascular risks in long-term use. Paracetamol has modest effects and a favourable safety profile. Duloxetine (a serotonin-norepinephrine reuptake inhibitor) is licensed for chronic musculoskeletal pain and provides additional benefit in patients with central sensitisation.

Injections: Steroid injections (cortisone) into the knee joint reduce inflammation for 4–12 weeks and are useful for acute flares; more frequent use may accelerate cartilage loss. Hyaluronic acid (viscosupplementation) injections have variable evidence. Platelet-rich plasma (PRP) shows benefit in mild-to-moderate OA in recent meta-analyses but less evidence in severe end-stage disease.

Knee unloader bracing: A custom-fitted valgus brace shifts load away from the medial compartment. Useful for patients with isolated medial OA who are not yet surgical candidates or who decline surgery.

High tibial osteotomy (HTO): A surgical bone cut that realigns the knee to shift body weight off the arthritic compartment. Suitable for younger patients (typically under 60) with isolated medial OA and varus deformity who remain physically active. HTO can delay TKA by 10–15 years in well-selected patients, preserving natural joint tissue.